Allgenesis Biotherapeutics Inc.
PrivateCompany Overview
Allgenesis Biotherapeutics Inc. is a biopharmaceutical company that focuses on the research and development of novel ophthalmic medicines for the treatment of eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
ophthalmic therapiesbiopharmaceuticalretinal diseasesbi-specific fusion proteindrug discoveryclinical-stage biotechdry eye diseasediabetic macular edemaDMEneovascular age-related macular degenerationnAMDtyrosine kinase inhibitordrug licensingophthalmology pipelinebiotech startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allgenesis Biotherapeutics Inc. Comparables
Compare Allgenesis Biotherapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Memento Medicines | 83% | |
| MabTics Co., Ltd. | 82% | |
| INGENIA Therapeutics | 82% | |
Allgenesis Biotherapeutics Inc. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Allgenesis Biotherapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allgenesis Biotherapeutics Inc.'s valuation, stock price, and market status.